On Tuesday, NRx Pharmaceuticals Inc. (NRXP) announced the pricing of shares offering at $0.30 per share, to raise $1.5 million, in addition to an investor commitment of $1 million in the company.
The biopharmaceutical company plans to use the proceeds for debt repayment, working capital and other corporate-related purposes.
Additionally, the company had offered a 45-day option to underwriters to purchase an additional 750,000 shares.
The offering is expected to close on February 28.
In the pre-market activity, NRx's stock is trading at $0.2877, down 32.64 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.